154288-17-2 Usage
Uses
Used in Pharmaceutical Industry:
4-CHLORO-8-METHOXY-2-METHYL-QUINAZOLINE is used as an intermediate in the synthesis of potential anti-cancer and anti-inflammatory drugs. Its unique chemical structure and properties make it a valuable component in the development of new medications.
Used in Research:
4-CHLORO-8-METHOXY-2-METHYL-QUINAZOLINE is used in research for its potential biological and pharmacological activities. Its exploration in scientific studies contributes to the understanding of its therapeutic potential and aids in the development of innovative treatments.
Used in Agrochemicals:
4-CHLORO-8-METHOXY-2-METHYL-QUINAZOLINE may have applications in the agrochemical industry, where it could be utilized in the development of new pesticides or other agricultural products.
Used in Materials Science:
In the field of materials science, 4-CHLORO-8-METHOXY-2-METHYL-QUINAZOLINE may have potential uses in the creation of new materials or the enhancement of existing ones, thanks to its unique chemical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 154288-17-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,2,8 and 8 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 154288-17:
(8*1)+(7*5)+(6*4)+(5*2)+(4*8)+(3*8)+(2*1)+(1*7)=142
142 % 10 = 2
So 154288-17-2 is a valid CAS Registry Number.
154288-17-2Relevant academic research and scientific papers
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a]pyridine moiety
Abe, Yoshito,Kayakiri, Hiroshi,Satoh, Shigeki,Inoue, Takayuki,Sawada, Yuki,Inamura, Noriaki,Asano, Masayuki,Aramori, Ichiro,Hatori, Chie,Sawai, Hiroe,Oku, Teruo,Tanaka, Hirokazu
, p. 4062 - 4079 (2007/10/03)
Recently we reported on overcoming the species difference of our first orally active non-peptide bradykinin (BK) B2 receptor antagonists, incorporating an 8-[[3-(N-acylglycyl-N-methylamino)-2,6-dichlorobenzyl]oxy]- 3-halo-2-methylimidazo[1,2-α]
